Cytoplasmic transfer in oocytes: biochemical aspects

Area of Science:

• Reproductive biology
• Developmental biology
• Assisted reproductive technology

Background:

• Cytoplasmic transfer, first used in mice in the 1980s to overcome the 2-cell block, involves transferring cytoplasm between oocytes.
• Since 1997, over 30 children have been born following human oocyte cytoplasm transfer, often using a modified ICSI technique.
• The rapid clinical application in humans has outpaced comprehensive research on its efficacy and potential risks.

Purpose of the Study:

• To review the biochemical mechanisms potentially underlying the benefits of ooplasm transfer.
• To evaluate the current empirical status and associated risks of ooplasm transfer in human assisted reproduction.

Main Methods:

• Review of existing literature on cytoplasmic transfer and ooplasm transfer techniques.
• Analysis of proposed biochemical pathways, including apoptotic factor balance and mitochondrial function.

Main Results:

• Ooplasm transfer may benefit embryo development by correcting imbalances in anti- and pro-apoptotic factors.
• Correction of defective mitochondrial membrane potential is another proposed mechanism for improved outcomes.
• The technique remains largely empirical, with limited data on long-term safety and efficacy.

Conclusions:

• Ooplasm transfer presents potential biochemical benefits for preimplantation development.
• The clinical application of ooplasm transfer in humans is empirical and warrants further investigation into its efficacy and risks.
• More research is needed to fully understand and validate the safety and effectiveness of this assisted reproductive technology.